# Epidiolex in Typical Absence Seizures

> **NCT04899050** · PHASE4 · COMPLETED · sponsor: **University of South Florida** · enrollment: 14 (actual)

## Conditions studied

- Study the Efficacy of Epidiolex for Typical Absence Seizures

## Interventions

- **DRUG:** Cannabidiol (Epidiolex)

## Key facts

- **NCT ID:** NCT04899050
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-30
- **Primary completion:** 2023-05-27
- **Final completion:** 2023-05-27
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04899050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04899050, "Epidiolex in Typical Absence Seizures". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04899050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*